Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02375958 |
| Title | PCA062 in pCAD-positive Tumors. |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ITA | FRA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | Houston | Texas | 77030 | United States | Details | |
| Novartis Investigative Site | San Antonio | Texas | 78229 | United States | Details | |
| Novartis Investigative Site | Villejuif Cedex | 94805 | France | Details | ||
| Novartis Investigative Site | Milano | MI | 20133 | Italy | Details | |
| Novartis Investigative Site | Koto ku | Tokyo | 135 8550 | Japan | Details | |
| Novartis Investigative Site | Singapore | 169610 | Singapore | Details | ||
| Novartis Investigative Site | Madrid | 28009 | Spain | Details |